Infliximab for the treatment of rheumatoid arthritis.
BACKGROUND: Infliximab is a human murine chimeric anti-tumour necrosis factor alpha monoclonal antibody recently approved for the treatment of refractory RA. OBJECTIVES: To assess the efficacy and safety of infliximab for the treatment of rheumatoid arthritis. SEARCH STRATEGY: Electronic databases...
Asıl Yazarlar: | Blumenauer, B, Judd, M, Wells, G, Burls, A, Cranney, A, Hochberg, M, Tugwell, P |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2002
|
Benzer Materyaller
-
Etanercept for the treatment of rheumatoid arthritis.
Yazar:: Blumenauer, B, ve diğerleri
Baskı/Yayın Bilgisi: (2003) -
Etanercept for the treatment of rheumatoid arthritis
Yazar:: Blumenauer, B, ve diğerleri
Baskı/Yayın Bilgisi: (2004) -
Etanercept for the treatment of rheumatoid arthritis.
Yazar:: Lethaby, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
Infliximab in the treatment of rheumatoid arthritis
Yazar:: A Perdriger
Baskı/Yayın Bilgisi: (2009-05-01) -
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
Yazar:: Jobanputra, P, ve diğerleri
Baskı/Yayın Bilgisi: (2002)